Nelson D R, Palmer K J, Johnson A M
SmithKline Beecham Pharmaceuticals, Research and Development, Harlow, Essex, UK.
Life Sci. 1990;47(18):1683-91. doi: 10.1016/0024-3205(90)90375-2.
The effects of prolonged (21 day) oral administration of the antidepressants paroxetine (0.9 to 8.9 mg/kg/day) and amitriptyline (2.7 to 27 mg/kg/day), on rat brain cortical beta 1- and beta 2-adrenoceptor numbers and affinities were investigated using [3H]-CGP 12177. Although amitriptyline, 27 mg/kg, caused a significant (p less than 0.05) 20% reduction in the number of beta 1-adrenoceptors, paroxetine, at doses up to 8.9 mg/kg p.o., did not influence binding of [3H]-CGP 12177 to cortical beta 1- or beta 2-adrenoceptors. This study with paroxetine provides further evidence that the down-regulation of central beta 1-adrenoceptors in rat brain after repeated administration is not a property of all antidepressant drugs.
使用[3H]-CGP 12177研究了抗抑郁药帕罗西汀(0.9至8.9毫克/千克/天)和阿米替林(2.7至27毫克/千克/天)持续口服给药21天对大鼠脑皮质β1-和β2-肾上腺素能受体数量及亲和力的影响。尽管27毫克/千克的阿米替林使β1-肾上腺素能受体数量显著减少(p<0.05)达20%,但口服剂量高达8.9毫克/千克的帕罗西汀并未影响[3H]-CGP 12177与皮质β1-或β2-肾上腺素能受体的结合。这项关于帕罗西汀的研究进一步证明,反复给药后大鼠脑中中枢β1-肾上腺素能受体的下调并非所有抗抑郁药物的特性。